Bonatra increasing continual illness administration platform with MyAva acquisition
Bonatra, which is as soon as centered on treating continual well being situations in males, is increasing its platform to cope with girls’s well being and wellness by means of its newest acquisition of MyAva.
Based in 2019, the femtech startup offers curated programmes and personalised plans to assist girls handle their continual situations, together with PCOS and thyroid problems.
“Buying MyAva permits us to increase our attain and deepen our experience in girls’s well being, particularly for situations like PCOS,” mentioned Bonatra CEO and co-founder Rahul Kishore Singh. Bonatra presents personalised therapy plans primarily based on IoMT-collected information to assist males deal with and handle their continual situations, corresponding to hypertension and diabetes.
MyAva CEO and founder mentioned they’re elated to hitch Bonatra and “additional the imaginative and prescient of constructing continual care administration accessible to all girls” whereas strengthening their joint commitments to “making femtech extra inclusive and built-in.”
Startoon will get US FDA clearance for wearable restoration monitoring system
Indian medical system startup Startoon Labs has acquired the USA Meals and Drug Administration’s 510(ok) clearance for its flagship wearable well being product.
Known as Pheezee, the system measures the floor electromyogram of bulk muscle tissue and the vary of movement of main joints to find out joint well being. It’s meant to be used in monitoring sufferers’ restoration from physiotherapy, neurological, and musculoskeletal accidents.
Indian researchers use ML to detect CNS tumours
Researchers on the Indian Institute of Expertise Madras have developed an ML-based computational software to higher detect cancer-causing tumours within the mind and spinal twine.
Out there publicly on-line, the GBMDriver (GlioBlastoma Mutiforme Drivers) identifies driver mutations and passenger mutations in glioblastoma, that are key to growing therapeutic choices for sufferers.
Ubie expands uncommon illnesses partnership with Takeda
Japanese well being tech startup Ubie has expanded its digital transformation partnership with Takeda Pharmaceutical Co.
The expanded collaboration, in response to a press assertion, seeks to advertise the early detection of uncommon illnesses and gastrointestinal illnesses. The 2 firms began their partnership in 2021 with the promotion of Ubie’s symptom checker and affected person consumption type.
Ubie additionally intends to introduce further features on high of its present choices and to collaborate with Takeda on IT programs and information.
